Compare the effects of different visfatin concentration on cardiovascular risk factors, adiponectin and insulin resistance in patients with T2DM-Reference-Cited by-同舟云学术

Compare the effects of different visfatin concentration on cardiovascular risk factors, adiponectin and insulin resistance in patients with T2DM

Published:2011-04 Issue:2 Volume:5 Page:71-75
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Mohammadi Somayeh,Hosseinzadeh-Attar Mohammad Javad,Hosseinnezhad Arash,Hosseini Seyyed Hossein,Eshraghian Mohammad Reza,Nezhad Mohammad Kamali,Rahmani Mazaher,Karimi Mehrdad

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Lifetime costs of complications resulting from type 2 diabetes in the U.S.;Caro;Diabetes Care,2002

2. Diabetes and atherosclerosis: an epidemiologic view;Pyorala;Diabetes Metab Rev,1987

3. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study;de Vegt;Diabetologia,1999

4. Diabetes and cardiovascular risk factors: the Framingham study;Kannel;Circulation,1979

5. Heart disease and diabetes;Wingard,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of serum and salivary visfatin levels in newly diagnosed patients of type-II DM;Journal of Oral and Maxillofacial Pathology;2023

2. Health Benefits of Endurance Training: Implications of the Brain-Derived Neurotrophic Factor—A Systematic Review;Neural Plasticity;2019-06-24

3. Loureirin B promotes insulin secretion through inhibition of K ATP channel and influx of intracellular calcium;Journal of Cellular Biochemistry;2017-09-11

4. The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes;BioMedicine;2015-08-13

5. Adiponectin as a potential biomarker of vascular disease;Vascular Health and Risk Management;2015-01